In vitro and pharmacokinetic properties of the carbapenems

No abstract is available for this paper.

• Publication year

  1986

• Venue

  Antimicrobial Agents and Chemotherapy

• Publication date

  1986-09-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1128/AAC.30.3.343PMID 3535659PMCID PMC180556
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Beta-lactamases with high activity against imipenem and Sch 34343 from Aeromonas hydrophila.

  1986cited by this paper
• Efficacy and safety of imipenem/cilastatin: a review of worldwide clinical experience.

  1985cited by this paper
• Imipenem-induced resistance to antipseudomonal beta-lactams in Pseudomonas aeruginosa

  1985cited by this paper
• Synthetic carbapenem antibiotics III. 1-Methyl thienamycin

  1985cited by this paper
• Antibacterial activity of imipenem: the first thienamycin antibiotic.

  1985cited by this paper
• Role of beta-lactam hydrolysis in the mechanism of resistance of a beta-lactamase-constitutive Enterobacter cloacae strain to expanded-spectrum beta-lactams

  1985cited by this paper
• Novel carbapenem derivative SF2103A: studies on the mode of beta-lactamase inactivation

  1984cited by this paper
• Disposition of radiolabeled imipenem and cilastatin in normal human volunteers

  1984cited by this paper
• Multiple-dose pharmacokinetics of imipenem-cilastatin

  1984cited by this paper
• Thienamycin: development of imipenem-cilastatin

  1983cited by this paper
• Pharmacokinetics and tolerance of N-formimidoyl thienamycin (MK0787) in humans

  1983cited by this paper
• Properties of MM 13902 and other carbapenem antibiotics in vitro and in vivo.

  1983cited by this paper
• Urinary Recovery of N-Formimidoyl Thienamycin (MK0787) as Affected by Coadministration of N-Formimidoyl Thienamycin Dehydropeptidase Inhibitors

  1983cited by this paper
• Thienamycin: development of imipenen-cilastatin.

  1983cited by this paper
• A novel beta-lactamase inhibitor, SF-2103 A produced by a Streptomyces.

  1982cited by this paper
• SQ 27,860, a simple carbapenem produced by species of Serratia and Erwinia.

  1982cited by this paper
• The structures of pluracidomycins, new carbapenem antibiotics.

  1982cited by this paper
• The carbapenem family.

  1982cited by this paper
• Metabolism of Thienamycin and Related Carbapenem Antibiotics by the Renal Dipeptidase, Dehydropeptidase-I

  1982cited by this paper
• PS-8, a minor carbapenem antibiotic.

  1982cited by this paper
• N-Formimidoyl-thienamycin a novel β-actam: an in-vitro comparison with other β-lactam antibiotics

  1981cited by this paper
• Asparenomycin A, a new carbapenem antibiotic.

  1981cited by this paper
• N-formimidoyl-thienamycin a novel beta-lactam: an in-vitro comparison with other beta-lactam antibiotics.

  1981cited by this paper
• N-ACETIMIDOYL- AND N-FORMIMIDOYLTHIENAMYCIN DERIVATIVES: ANTIPSEUDOMONAL β-LACTAM ANTIBIOTICS

  1980cited by this paper
• Comparative antibacterial properties in vitro of seven olivanic acid derivatives: MM 4550, MM 13902, MM 17880, MM 22380, MM 22381, MM 22382 and MM 22383.

  1980cited by this paper
• Carpetimycins A and B, new beta-lactam antibiotics.

  1980cited by this paper
• PS-6 and PS-7, new beta-lactam antibiotics. Isolation, physicochemical properties and structures.

  1980cited by this paper
• MK0787 (N-formimidoyl thienamycin): evaluation of in vitro and in vivo activities

  1980cited by this paper
• CARPETIMYCINS A AND B, NEW β-LACTAM ANTIBIOTICS

  1980cited by this paper
• Thienamycin, a new beta-lactam antibiotic. I. Discovery, taxonomy, isolation and physical properties.

  1979cited by this paper
• N-Acetimidoyl- and N-formimidoylthienamycin derivatives: antipseudomonal beta-lactam antibiotics.

  1979cited by this paper
• Olivanic acids, a family of beta-lactam antibiotics with beta-lactamase inhibitory properties produced by Streptomyces species. II. Isolation and characterisation of the olivanic acids MM 4550, MM 13902 and MM 17880 from Streptomyces olivaceus.

  1979cited by this paper
• In Vitro Activity of Thienamycin

  1978cited by this paper
• PS-5, a new beta-lactam antibiotic from Streptomyces.

  1978cited by this paper
• Structure elucidation of MM 17880, a new fused β-lactam antibiotic isolated from Streptomyces olivaceus; a mild β-lactam degradation reaction

  1977cited by this paper
• Naturally-occurring beta-lactamase inhibitors with antibacterial activity.

  1976cited by this paper
• The β-Lactamases of Gram-Negative Bacteria and their Possible Physiological Role

  1973cited by this paper
• The beta-lactamases of gram-negative bacteria and their possible physiological role.

  1973cited by this paper
• Role of ,B-Lactam Hydrolysis in the Mechanism of Resistance of a 3-Lactamase-Constitutive Enterobacter cloacae Strain to Expanded-Spectrum r-Lactams

  year unknowncited by this paper

• Imipenem/cilastatin encapsulated polymeric nanoparticles for destroying carbapenem-resistant bacterial isolates

  2017cites this paper
• Identification and Characterization of the Carbapenem MM 4550 and its Gene Cluster in Streptomyces argenteolus ATCC 11009

  2014cites this paper
• Screening for a novel antimicrobial interaction for combination therapy

  2013cites this paper
• Prevalence of Carbapenemases in Acinetobacter baumannii

  2012cites this paper
• Carbapenems in the USA: focus on doripenem

  2007cites this paper
• Pharmacokinetics of Imipenem in Sheep with Special Reference to Its Hepato-Renal Effects

  2007cites this paper
• Effect of Bile Duct Obstruction on the Biliary Secretion of Meropenem in Rats

  2005cites this paper
• Synthesis and Antibacterial Activities of 4‐Pyrrolidinylthio Carbapenems: Containing Heteroaromatics as a Side Chain

  2003cites this paper
• Synthesis and antibacterial activity of 1beta-methyl-2-(5-substituted thiazolidinopyrrolidin-3-ylthio)carbapenems and related compounds.

  2002cites this paper
• Recent developments in carbapenems

  2002cites this paper
• Cellular and molecular aspects of drugs of the future: meropenem

  2002cites this paper
• In-vitro activities of various antibiotics, alone and in combination with amikacin against Pseudomonas aeruginosa.

  2001cites this paper
• Advances in the use of carbapenem antibiotics in the management of serious bacterial infections in special patient populations. I: Safety and efficacy in children and elderly patients

  2000cites this paper
• Imipenem and meropenem

  1999cites this paper
• Synthesis and structure-activity relationship of 2-(5-substituted pyrrolidin-4-ylthio)-1 beta-carbapenems.

  1997cites this paper
• The pharmacology of meropenem, a new carbapenem antibiotic.

  1997cites this paper
• Analysis of the carbapenem gene cluster of Erwinia carotovora: definition of the antibiotic biosynthetic genes and evidence for a novel β‐lactam resistance mechanism

  1997cites this paper
• Use of meropenem in the treatment of serious infections in children: review of the current literature.

  1997influential citation
• Meropenem: a new, extremely broad spectrum beta-lactam antibiotic for serious infections in pediatrics.

  1997cites this paper
• Synthesis and structure-activity relationship of 2-(5-substituted pyrrolidin-4-ylthio)-1β-carbapenems

  1997cites this paper
• In vitro activity of biapenem against recent gram-negative and gram-positive clinical isolates.

  1997cites this paper
• Recent advances in the chemistry and biology of carbapenem antibiotics.

  1996cites this paper
• In vitro antimicrobial activity and structure-activity relationship of C-2 triazolylthio and pyridinylmethylthio carbapenems.

  1996cites this paper
• Co-ordinate regulation of antibiotic and pigment production by the Serratia Rap protein : evidence for a novel family of regulatory proteins

  1996cites this paper
• Sequential, single-dose pharmacokinetic evaluation of meropenem in hospitalized infants and children

  1995cites this paper
• Meropenem Clinical Pharmacokinetics

  1995cites this paper
• Bacterial resistance to carbapenems.

  1995cites this paper
• Effect of five irreversible inhibitors on beta-lactamase from Shigella flexneri UCSF-129.

  1993cites this paper
• Comparative stability of carbapenem and penem antibiotics to renal dehydropeptidase-I.

  1993cites this paper
• Antimicrobial activity of the new carbapenem biapenem compared to imipenem, meropenem and other broad-spectrum beta-lactam drugs

  1993cites this paper
• Inactivation of new carbapenem antibiotics by dehydropeptidase-I from porcine and human renal cortex.

  1992cites this paper
• Renal dehydropeptidase-I stability of LJC 10,627, a new carbapenem antibiotic

  1992cites this paper
• Analysis of two gene regions involved in the expression of the imipenem-specific, outer membrane porin protein OprD of Pseudomonas aeruginosa.

  1992cites this paper
• Analysis of two gene regions involved in the expression of the imipenem-specific, outer membrane porin protein OprD of Pseudomonas aeruginosa

  1992cites this paper
• In-vitro activity of meropenem, a new carbapenem, against imipenem-resistant Pseudomonas aeruginosa and Xanthomonas maltophilia.

  1991cites this paper
• Meropenem: in-vitro activity and kinetics of activity against organisms of the Bacteroides fragilis group.

  1991cites this paper
• In vitro and in vivo activities of LJC10,627, a new carbapenem with stability to dehydropeptidase I

  1991influential citation
• The carbapenems and penem antibiotics—a brief review

  1990cites this paper
• Meropenem pharmacokinetics and penetration into an inflammatory exudate

  1990cites this paper
• Multicenter in vitro evaluation of SM-7338, a new carbapenem

  1989cites this paper
• Update on the antibacterial activity of the carbapenems

  1989cites this paper
• In-vitro studies of meropenem.

  1989cites this paper
• In vitro activity and beta-lactamase stability of a new carbapenem, SM-7338

  1989cites this paper
• The carbapenems: new broad spectrum beta-lactam antibiotics.

  1989cites this paper
• Stability of SM-7338, a new carbapenem in mediums recommended for the susceptibility testing of anaerobic bacteria and gonococci.

  1989cites this paper
• Evaluation of a disk approximation test of inducible beta‐lactamases in Enterobacteriacae and Pseudomonas aeruginosa

  1989cites this paper
• New antibiotics: areas of appropriate use.

  1987cites this paper
• Cephalosporin, carbapenem, and monobactam antibiotics.

  1987cites this paper